Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 2/20 | 0.62 |
| ▸ | ALOX5 | P09917 | 6/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.44 |
| ▸ | JAK2 | O60674 | 1/20 | 0.40 |
| ▸ | JAK1 | P23458 | 1/20 | 0.40 |
| ▸ | TYK2 | P29597 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | JAK3 | P52333 | 1/20 | 0.40 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.40 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.40 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.40 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8156367 | 0.93 | HMGCR (0.68) | HMGCRALOX5GABRA1GABRB2TAAR1 | |
| SCHEMBL11793593 | 0.87 | HMGCR (0.81) | HMGCRALOX5GABRA1GABRB2TAAR1 | |
| SCHEMBL18867913 | 0.77 | HMGCR (0.66) | HMGCRTAAR1HTR2AHTR2C | |
| SCHEMBL1276493 | 0.77 | HMGCR (1.00) | HMGCRALOX5GABRA1GABRB2 | |
| SCHEMBL12847172 | 0.77 | HMGCR (0.41) | HMGCRALOX5GABRA1GABRB2JAK2 | |
| SCHEMBL29151839 | 0.76 | HMGCR (0.65) | HMGCRALOX5TAAR1HTR2A | |
| SCHEMBL15356820 | 0.76 | HMGCR (0.65) | HMGCRALOX5GABRA1GABRB2TAAR1 | |
| SCHEMBL11392839 | 0.76 | HMGCR (0.52) | HMGCRALOX5TAAR1KDR | |
| SCHEMBL18179321 | 0.76 | HMGCR (0.44) | HMGCRALOX5 | |
| SCHEMBL8614276 | 0.75 | HMGCR (0.47) | HMGCRALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170362508-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | DIC CORPORATION (JP) | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170362508-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | PBDC1, RCC1, PUF60 | HMGCR 2555/4885ALOX5 953/4885GABRA1 4241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.